𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of drug resistance-associated markers P-GP, MRP1, MRP2 and LRP in ovarian cancer: clinical implications

✍ Scribed by D. Katsaros; H.J.G. Arts; M. Massobrio; A.J.H. Van der Zee

Book ID
117123762
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
155 KB
Volume
70
Category
Article
ISSN
0020-7292

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Copper-transporting P-type adenosine tri
Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: Comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP
✍ Kentaro Nakayama; Atsuko Kanzaki; Kenji Ogawa; Kohji Miyazaki; Nouri Neamati; Yu πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 224 KB

## Abstract Intrinsic or acquired resistance to chemotherapy is the major obstacle to overcome in the treatment of patients with solid carcinoma. Cisplatin is one of the most effective chemotherapeutic agents for treating ovarian carcinoma. Recently, copper‐transporting P‐type adenosine triphosphat